Document is current
Any future updates will be listed below
-
Authors
Karandish, Majid
Mozaffari-khosravi, Hassan
Mohammadi, Seyed Mohammad
Cheraghian, Bahman
Azhdari, Maryam https://orcid.org/0000-0003-2110-9817
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20190902044671n1 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Curcumin and zinc co-supplementation along with a loss-weight diet can improve lipid profiles in subjects with prediabetes: a multi-arm, parallel-group, randomized, double-blind placebo-controlled phase 2 clinical trial
https://doi.org/10.1186/s13098-022-00792-2
-
Funding
Funding for this research was provided by:
Ahvaz Jundishapur University of Medical Sciences (8913)
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 10 January 2022
First Online: 28 January 2022
Declarations
:
: This trial was approved by the Medical Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Ethical code: IR.AJUMS.REC.1398.504) in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The written informed consent was obtained from all patients to participate in this study after receiving a complete explanation of the study protocols and objectives.
: The authors affirm that human research participants provided informed consent for publication of their data.
: The authors declare no competing interests associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
